|
AC-TH was the gold standard when I was diagnosed in October 2005. If ASCO considers TCH just as good, that's wonderful news. I am glad that women today can avoid the Adriamycin. It's a particularly harsh drug, although it saved a lot of lives before alternatives came along. There is so much going on in cancer research that I am not surprised that things have changed in less than two years. Nobody can make the decision but you; however, if TCH is considered as effective as AC-TH, I know what I'd do if I had to do it again (And I never will!)
__________________
MJO
IDC, Stage I, Grade 2
Oncotype DX Score 32
Her2++ E+P+, Node Neg.
Lumpectomy 11/04/05 Clear Margins
3 Dose dense AC (Couldn't tolerate 4)
4 Dose dense Taxol & Herc. (Tolerated well)
36 weeks Herceptin (Could not complete one year due to decrease in MUGA score)
2 years of Arimidex, then three years of Femara
Finished Femara May 2011
|